Subclinical hypothyroidism* is a common problem. Subclinical patients have raised TSH level and normal level of serum thyroid hormones. The most common cause of elevated TSH is autoimmune thyroid disease (Hashimoto’s). In most of the cases increased antibodies are also present.
Subclinical hypothyroidism’s prevalence is 3% to 8% in patients without known thyroid disease and increases with age: 8%-18% in adults 65 years or older. Subclinical patients are much more opt to coronary heart disease, psychiatric disorders, and pregnancy problems.
Diagnosing on time subclinicals and properly treating them is essential in order to slow down the progression of the disease and in order to the manage the risk of other health complaints.
There is insufficient scientific support of the benefit for levothyroxine therapy in patients with subclinical hypothyroidism, in particular for the group with TSH less than 10 mIU/L.
Are you transferred to one medical professional to the other without being helped?
What if there is way?
Have you thought about reprogramming your immune imbalance?
Contact us: email@example.com